Cabrera AI, Díaz de la Fe A, Baez MM, Zamora PF, Martínez MMI, Robinson AMÁ, Díaz RB

Language: Spanish
References: 0
Page:
PDF size: 197.72 Kb.

ABSTRACT

Introduction. Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. It is considered as the most prevalent and disabling non-traumatic disease affecting the population of young and middle-aged adults. The presence of cognitive affections in these patients is known. Objectives. To describe the superior psychic functions in patients with Multiple Sclerosis treated and not treated with Rebif and to identify the most affected functions. Methods. We studied 26 patients treated at the International Center for Neurological Restoration, divided into two groups: 13 patients with Multiple Sclerosis (treated with Rebif) and 13 untreated patients. The clinical variables, such as subtype of MS, duration of disease, medication and neuropsychological profile were analyzed Results. the study showed that most of the patients treated and not treated with Rebif presented cognitive alterations. The most affected functions were attention, long-term memory and executive functions. Patients treated with Rebif reported fewer symptoms of depression than those not treated. No relationship was found between clinical variables and cognitive impairment. Conclusions. The Superior Psychic Functions are affected in patients with Multiple Sclerosis treated and not treated with Rebif. Depression was lower in patients treated with Rebif.